Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199212-12-2014
12-12-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199225-11-2014
Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Health Sciences Pvt Ltd has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE11-11-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199204-11-2014
Outcome of Board Meeting
Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2014, inter alia, has:- Allotted 12,22,472 fully-paid up Equity Shares of Face Value of Rs. 10 each, out of the Rights Issue of 12,25,276 Equity shares and the balance has been kept in abeyance.29-10-2014
Financial Results & Limited Review for Sept 30, 2014 (Standalone)
Neuland Laboratories Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014.29-10-2014
Closure of Trading Window
Neuland Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on October 29, 2014, inter alia, to consider and take on record the unaudited financial results of the Company for the quarter ended September 30, 2014.Further, as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from October...16-10-2014
Shareholding Pattern For September 30, 2014
Neuland Laboratories Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014.10-10-2014
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199209-10-2014
Newspaper publication issued in respect of dispatch of Abridged Letter of Offer and Composite Application Form for the Rights Issue
Neuland Laboratories Ltd has submitted to BSE a copy of newspaper publication on September 25, 2014 in respect of dispatch of Abridged Letter of Offer and Composite Application Form for the Rights Issue to the eligible Equity shareholders.25-09-2014